ArticleNeurocritical care2026
Pediatric Neurogenic Stunned Myocardium: A Systematic Review and Pooled Individual-Level Analysis.
Article in Neurocritical care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNeurogenic stunned myocardium (NSM) is a reversible cardiac dysfunction after acute neurological injury that is well described in adults but poorly characterized in children.
objectiveThe purpose of this study was to characterize pediatric NSM and identify factors associated with neurological outcome using individual patient data (IPD).
methodsA systematic review and pooled individual-level analysis were conducted according to Meta-analysis Of Observational Studies in Epidemiology (MOOSE) guidelines. PubMed, Web of Science, and Cumulative Index to Nursing and Allied Health Literature (CINAHL) were searched from inception to November 2025 for studies reporting patients ≤ 18 years with NSM and available outcome data. Demographic, neurological, and cardiac variables were extracted. Functional outcomes were assessed using the modified Rankin Scale (mRS).
resultsA total of 29 studies comprising 38 patients were included (mean age 7.7 years). The mean time to NSM onset was 60.8 h after neurological injury. Ventricular dysfunction occurred in 94.7%, commonly basal hypokinesis. Favorable outcome (mRS 0-2) occurred in 71.1%, while cardiac arrest occurred in 26.3% and mortality in 23.7%. Subarachnoid hemorrhage was associated with a worse outcome, whereas absence of pupil abnormalities and preserved reflexes were associated with a favorable outcome.
conclusionsPediatric NSM is usually reversible with favorable neurological outcomes but remains associated with significant morbidity and mortality. Early recognition and multidisciplinary management may improve outcomes. Larger prospective studies are needed to refine prognostic stratification.
Indexed as
Identifiers
42768268What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.